Recombinant Mouse Probable C-C chemokine receptor type 3 (Ccr3)

What is the molecular structure of mouse CCR3 and how does it compare to human CCR3?

Mouse CCR3 is a seven-transmembrane G protein-coupled receptor encoded by the gene located on chromosome 9. The mouse CCR3 protein consists of 359 amino acids (Met1-Phe359) and has an accession number of P51678 . While mouse and human CCR3 share significant homology, there are species-specific differences that researchers should consider when designing experiments or interpreting results from mouse models.

Mouse CCR3 has evolved as part of the inflammatory chemokine receptor (iCCR) family, which includes CCR1, CCR2, and CCR5. These receptors show selective expression patterns in individual cell types, contradicting earlier assumptions about extensive functional redundancy . When developing antibodies or designing targeting strategies, it's crucial to account for the high degree of homology between different iCCRs, which can lead to non-specific binding if proper controls aren't used .

Which cell types express CCR3 in mice and how is this expression regulated?

In mice, CCR3 is predominantly expressed on:

• Eosinophils (highest expression)

• Basophils

• Mast cells

• Subsets of dendritic cells

• Certain T helper cell populations

CCR3 expression is dynamically regulated during immune responses. Flow cytometry analysis of mouse splenocytes has confirmed CCR3 expression on specific cell populations, particularly when co-stained with markers like Gr-1/Ly-6G . The regulation of CCR3 expression involves both transcriptional and post-transcriptional mechanisms, including cytokine-mediated induction and receptor internalization following ligand binding.

Recent studies using transgenic reporter mice have revealed that CCR3 expression patterns are more selective than previously anticipated, with specific expression profiles in resting and inflammatory conditions . This selective expression suggests limited functional redundancy with other chemokine receptors, highlighting CCR3's distinct role in immune cell trafficking.

What are the most reliable methods for detecting CCR3 expression in mouse samples?

Several methodological approaches can be used to detect CCR3 expression, each with specific advantages:

Flow Cytometry:

• Fluorescein-conjugated antibodies (e.g., Clone #83101) allow for specific detection of CCR3 on cell surfaces

• When analyzing tissues, proper gating strategies and appropriate isotype controls are essential

• For optimal results, use freshly isolated cells as enzyme digestion can cleave the external portions of chemokine receptors, preventing antibody detection

Reporter Systems:

• Transgenic iCCR reporter (iCCR-REP) mice expressing spectrally distinct fluorescent proteins for CCR3 and other receptors provide superior specificity compared to antibody-based detection

• These systems allow simultaneous tracking of multiple chemokine receptors without antibody staining artifacts

Quantitative PCR:

• Useful for detecting CCR3 mRNA levels

• Should be complemented with protein detection methods due to potential post-transcriptional regulation

Important methodological consideration: Commercial antibodies for chemokine receptors frequently show background non-specific staining due to the high homology between different iCCRs. Researchers should always include appropriate knockout controls (e.g., CCR3-deficient mice) when validating antibody specificity .

How can CCR3-mediated migration be effectively measured in vitro?

The assessment of CCR3-mediated migration is critical for understanding receptor functionality. The following methodological approaches are recommended:

Transwell Migration Assay:

• Place CCR3-expressing cells in the upper chamber and chemokines (e.g., eotaxin-1 at 100 nM) in the lower chamber

• Quantify migration as either percent cell migration relative to control or as average number of cells per field

• Include appropriate controls, such as cells with receptor antagonists or cells from receptor-deficient mice

Microfluidic Devices:

• Allow for the measurement of migration toward both substrate-bound and soluble chemokine gradients

• Provide more physiologically relevant conditions than traditional Transwell assays

Chemotaxis Analysis Workflow:

• Isolate target cells (e.g., bone marrow-derived eosinophils)

• Confirm CCR3 expression by flow cytometry

• Prepare chemokine dilutions (typically 1-100 nM range)

• Conduct migration assay (2-4 hours for optimal results)

• Quantify migrated cells and calculate migration index

As demonstrated in studies with Galectin-3 deficient eosinophils, CCR3-mediated migration toward eotaxin-1 can be significantly affected by molecular interactors, highlighting the importance of comprehensive controls in migration experiments .

How can transgenic CCR3 reporter mice advance our understanding of inflammatory processes?

The development of transgenic iCCR reporter mice has revolutionized the study of chemokine receptor dynamics in vivo. These systems offer several key advantages for inflammatory research:

Temporal and Spatial Tracking:

• iCCR-REP mice expressing spectrally distinct fluorescent reporters for CCR1, CCR2, CCR3, and CCR5 allow for precise tracking of receptor expression during inflammatory responses

• These systems enable visualization of receptor expression changes in real-time as cells migrate from bone marrow to blood and into inflamed tissues

Combinatorial Expression Analysis:

• Reporter mice reveal the precise combinations of chemokine receptors expressed by individual cells

• This allows researchers to identify specific cellular subpopulations and their changing receptor profiles during differentiation and activation

Unbiased Assessment of Receptor Dynamics:

• Unlike antibody-based detection, reporter systems are not affected by receptor internalization or cleavage during tissue processing

• This provides more accurate data on receptor expression patterns in various physiological and pathological states

Research Applications:

• Tracking myeloid cell recruitment during acute and chronic inflammation

• Analyzing the hierarchy of chemokine receptor expression during differentiation

• Identifying target cell populations for therapeutic interventions

The iCCR-REP mouse strain has demonstrated that chemokine receptor expression is highly specific and more selective than previously anticipated, challenging the notion of extensive redundancy in the chemokine system .

What are the key considerations when designing experiments with CCR3-deficient mice?

When working with CCR3-deficient mice, researchers should consider several critical factors to ensure experimental validity and reproducibility:

Genetic Background Effects:

• Ensure CCR3-deficient mice and controls are on the same genetic background

• Different mouse strains can exhibit varying baseline levels of eosinophils and other CCR3-expressing cells

Compensatory Mechanisms:

• CCR3-deficient mice may develop compensatory upregulation of other chemokine receptors

• Assess expression of related receptors (CCR1, CCR2, CCR5) to identify potential compensation

Phenotyping Protocol:

• Confirm CCR3 deletion by genotyping

• Assess baseline hematopoietic parameters in bone marrow, blood, and tissues

• Evaluate functional responses (e.g., migration to CCR3 ligands) in isolated cells

• Compare inflammatory responses in disease models

Experimental Controls:

• Include both wild-type littermates and heterozygous animals when possible

• For experiments using the iCCR-REP system, proper controls would include animals derived from heterozygous crosses as mentioned in the literature

CCR3-deficient mice have been invaluable in demonstrating the non-redundant functions of this receptor in various inflammatory models, particularly in allergic inflammation and eosinophil trafficking.

How does CCR3 coordinate with other chemokine receptors during inflammatory responses?

CCR3 functions within a complex network of chemokine receptors that orchestrate leukocyte trafficking. Recent research using iCCR reporter mice has provided new insights into how these receptors coordinate:

Hierarchical Expression Patterns:

• Analysis of iCCR-REP mice has revealed that chemokine receptors display selective expression patterns in individual cell types during both resting and inflammatory states

• This selectivity suggests that each receptor plays a non-redundant role in leukocyte recruitment

Temporal Coordination:

• Different chemokine receptors are activated at distinct phases of the inflammatory response

• CCR3 is particularly important during allergic inflammation, while CCR2 often dominates in monocyte recruitment during bacterial infections

Functional Specialization:

• CCR3's primary function involves eosinophil recruitment and activation

• Other iCCRs like CCR2 are more critical for monocyte trafficking

• This specialization contradicts earlier assumptions about extensive functional redundancy

Cell-Specific Expression Profiles:

• Using iCCR-REP mice, researchers have demonstrated that bone marrow, peripheral blood, and tissue-resident myeloid cells express distinct patterns of chemokine receptors

• These expression patterns change dynamically during inflammatory responses

What is the relationship between CCR3 expression and cellular migration capacity?

The relationship between CCR3 expression levels and migration capacity is complex and depends on multiple factors:

Direct Correlation Studies:

• Research using fluorescein-conjugated anti-CCR3 antibodies has demonstrated that CCR3 expression levels on eosinophils directly correlate with their migration capacity toward CCR3 ligands like eotaxin-1

• For example, Galectin-3 deficient eosinophils show both decreased CCR3 expression and reduced migratory capacity toward eotaxin-1 (100 nM)

Receptor Density Effects:

Post-Receptor Signaling Efficiency:

• Migration capacity depends not only on receptor expression but also on the efficiency of downstream signaling pathways

• Different cell types may exhibit varying migratory responses despite similar CCR3 expression levels

Experimental Migration Data:

These findings highlight the important role of CCR3 expression in determining cellular migration capacity and identify molecular regulators like Galectin-3 that can influence this relationship .

How can CCR3 research in mouse models inform therapeutic approaches for human inflammatory diseases?

Mouse models of CCR3 function have provided valuable insights that inform therapeutic strategies for human inflammatory conditions:

Translational Relevance:

• Despite some species differences, the core functions of CCR3 in eosinophil trafficking are conserved between mice and humans

• Mouse models have helped identify key pathways and molecular interactions that can be targeted therapeutically

Disease-Specific Insights:

• In allergic asthma models, CCR3 blockade reduces eosinophil recruitment to the lungs

• In atopic dermatitis models, CCR3 antagonism decreases skin inflammation

• These findings have supported the development of CCR3 antagonists for human allergic diseases

Methodological Considerations for Translational Research:

• Use multiple mouse models that recapitulate different aspects of human disease

• Validate findings using human cells and tissues when possible

• Consider species differences in ligand-receptor interactions

• Employ reporter systems like iCCR-REP mice to track receptor dynamics in vivo

Therapeutic Targeting Approaches:

• Direct antagonism of CCR3 using small molecule inhibitors

• Biological therapies targeting CCR3 ligands

• Cell-specific delivery strategies that modulate CCR3 expression

The development of iCCR reporter mice has provided unprecedented ability to track chemokine receptor expression dynamics in vivo, offering new opportunities for testing targeted therapeutics and understanding their mechanisms of action in inflammatory conditions .

What methodological approaches are most effective for studying CCR3 in complex inflammatory models?

Studying CCR3 in complex inflammatory models requires integrated methodological approaches:

Multiparameter Analysis:

• Combine flow cytometry with CCR3 reporter systems to simultaneously track multiple parameters

• Use spectral flow cytometry to analyze complex combinations of iCCR expression on diverse cell populations

Tissue-Specific Considerations:

• When isolating cells from inflamed tissues, enzymatic digestion can cleave external portions of chemokine receptors, hampering antibody detection

• Reporter mice circumvent this issue by expressing fluorescent proteins that remain detectable after tissue processing

Temporal Analysis Protocol:

• Establish baseline CCR3 expression in resting state

• Induce inflammation using appropriate stimulus

• Collect samples at multiple time points (early, peak, and resolution phases)

• Track changes in CCR3 expression and CCR3+ cell populations

• Correlate with functional outcomes and disease parameters

Integration of Genetic and Pharmacological Approaches:

• Compare CCR3-deficient mice with wild-type animals treated with CCR3 antagonists

• This helps distinguish between developmental effects of receptor absence versus acute inhibition

Advanced Imaging Techniques:

• Intravital microscopy using iCCR-REP mice allows for real-time visualization of CCR3+ cell trafficking in vivo

• Two-photon microscopy enables deeper tissue imaging with reduced photobleaching

By implementing these methodological approaches, researchers can gain more comprehensive insights into the complex role of CCR3 in inflammatory processes and identify potential therapeutic targets with greater precision.